<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the effects of <z:chebi fb="9" ids="27656">CPT</z:chebi>-11 in combination with other anticancer agents, a human Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, Dauji, was incubated for 3 days in the presence of SN-38 (active substance of <z:chebi fb="9" ids="27656">CPT</z:chebi>-11) and the combined drug and cell growth inhibition was determined by <z:chebi fb="0" ids="53233">MTT</z:chebi> assay </plain></SENT>
<SENT sid="1" pm="."><plain>The effects of the drug combinations at ID50 were then analyzed by isobologram (Steel and Peckham) </plain></SENT>
<SENT sid="2" pm="."><plain>A supra-additive (synergistic) effect was observed for SN-38 in combination with <z:chebi fb="2" ids="31355">carboplatin</z:chebi>, <z:chebi fb="2" ids="27899">cisplatin</z:chebi>, <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi>, and <z:chebi fb="0" ids="27504">mitomycin C</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>An additive effect was observed for its combination with <z:chebi fb="0" ids="3139">bleomycin</z:chebi>, <z:chebi fb="0" ids="4911">etoposide</z:chebi>, <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>, and <z:chebi fb="0" ids="50729">mitoxantrone</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Additive and sub-additive (antagonistic) effects were observed in combination with <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>A Sub-additive effect was observed in combination with <z:chebi fb="0" ids="44185">methotrexate</z:chebi> and <z:chebi fb="0" ids="28445">vincristine</z:chebi> </plain></SENT>
</text></document>